Narrative Update • Jun 24
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 26, 2026
DataAggregated Company Financials
Companies9
- 7D16.1%
- 3M31.4%
- 1Y47.4%
- YTD22.1%
Over the last 7 days, the Pharma industry has risen 16%, driven by gains from Bayer of 27%. This means that the industry has gained 47% over the past year. As for the next few years, earnings are expected to grow by 23% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jun 2026 | €112.1b | €67.4b | €482.6m | 25.2x | 232.4x | 1.7x |
| Sun, 24 May 2026 | €96.9b | €67.4b | €511.4m | 22.1x | 189.4x | 1.4x |
| Tue, 21 Apr 2026 | €94.9b | €67.9b | -€888,586,162.20 | 19.1x | -106.8x | 1.4x |
| Thu, 19 Mar 2026 | €89.2b | €67.9b | -€900,288,464.41 | 18.7x | -99.1x | 1.3x |
| Sat, 14 Feb 2026 | €103.2b | €68.3b | €2.9b | 18x | 36x | 1.5x |
| Mon, 12 Jan 2026 | €96.8b | €68.3b | €2.9b | 18.3x | 33.8x | 1.4x |
| Wed, 10 Dec 2025 | €90.6b | €68.5b | €2.9b | 17.5x | 31.4x | 1.3x |
| Fri, 07 Nov 2025 | €77.0b | €68.8b | -€439,153,814.03 | 18.1x | -175.4x | 1.1x |
| Sun, 05 Oct 2025 | €83.9b | €68.8b | -€439,008,342.28 | 19.2x | -191.1x | 1.2x |
| Tue, 02 Sep 2025 | €77.7b | €68.9b | -€406,175,992.95 | 17.2x | -191.3x | 1.1x |
| Thu, 31 Jul 2025 | €79.3b | €69.4b | -€289,974,223.72 | 17.5x | -273.3x | 1.1x |
| Sat, 28 Jun 2025 | €77.9b | €69.4b | -€293,702,195.00 | 17.7x | -265.4x | 1.1x |
| Mon, 26 May 2025 | €76.2b | €69.4b | -€206,564,479.00 | 18.1x | -368.9x | 1.1x |
| Wed, 23 Apr 2025 | €74.9b | €69.3b | €463.1m | 17.9x | 161.7x | 1.1x |
| Fri, 21 Mar 2025 | €83.9b | €69.2b | €436.0m | 20.7x | 192.4x | 1.2x |
| Sun, 16 Feb 2025 | €82.8b | €69.2b | €2.0b | 21.9x | 40.9x | 1.2x |
| Tue, 14 Jan 2025 | €83.6b | €69.2b | €2.0b | 22.7x | 41.6x | 1.2x |
| Thu, 12 Dec 2024 | €84.9b | €69.2b | €2.0b | 22.1x | 41.9x | 1.2x |
| Sat, 09 Nov 2024 | €91.5b | €69.4b | €1.6b | 20.5x | 58.6x | 1.3x |
| Mon, 07 Oct 2024 | €99.0b | €69.3b | €1.5b | 21.6x | 67.3x | 1.4x |
| Wed, 04 Sep 2024 | €105.3b | €69.3b | €1.5b | 25.3x | 71.4x | 1.5x |
| Fri, 02 Aug 2024 | €102.4b | €69.2b | -€303,627,757.00 | 30.3x | -337.3x | 1.5x |
| Sun, 30 Jun 2024 | €95.7b | €69.2b | -€327,989,929.00 | 29.5x | -291.9x | 1.4x |
| Tue, 28 May 2024 | €103.2b | €69.2b | -€310,351,180.00 | 21.9x | -332.5x | 1.5x |
| Thu, 25 Apr 2024 | €95.0b | €70.0b | -€34,208,180.00 | 20.6x | -2777.9x | 1.4x |
| Sat, 23 Mar 2024 | €99.0b | €70.0b | €6.5m | 18.6x | 15246.5x | 1.4x |
| Mon, 19 Feb 2024 | €98.4b | €70.6b | -€650,504,143.00 | 19.4x | -151.3x | 1.4x |
| Wed, 17 Jan 2024 | €99.4b | €70.6b | -€650,504,143.00 | 20.5x | -152.8x | 1.4x |
| Fri, 15 Dec 2023 | €94.9b | €70.6b | -€650,606,256.00 | 18.6x | -145.9x | 1.3x |
| Sun, 12 Nov 2023 | €106.9b | €70.6b | -€625,796,256.00 | 16.7x | -170.9x | 1.5x |
| Tue, 10 Oct 2023 | €112.7b | €72.1b | €4.7b | 18.4x | 24.1x | 1.6x |
| Thu, 07 Sep 2023 | €125.1b | €72.1b | €4.7b | 21.9x | 26.9x | 1.7x |
| Sat, 05 Aug 2023 | €123.9b | €74.1b | €6.5b | 17.1x | 19.2x | 1.7x |
| Mon, 03 Jul 2023 | €118.8b | €74.1b | €6.5b | 18.5x | 18.4x | 1.6x |
Price to Earnings Ratio
18.4x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 232x which is higher than its 3-year average PE of 132x.
- The 3-year average PS ratio of 1.3x is lower than the industry's current PS ratio of 1.7x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | -0.77% | |
| Healthcare | 8.52% | |
| Pharma | 16.13% | |
| Pharma | 16.13% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €47.00 | 26.5% +€9.7b | 78.8% | PS1x | |
| MRK Merck KGaA | €147.00 | 10.5% +€6.1b | 31.7% | PE25.2x | |
| HIGH Cantourage Group | €6.26 | 0.3% +€249.4k | 17.2% | PE617.3x | |
| 27N0 Cannovum Cannabis | €0.44 | 10.6% +€97.1k | 107.1% | n/a |